Antimicrobial peptides and proteins in mycobacterial therapy: current status and future prospects (Q38210584)

31 August 2017

Antimicrobial peptides and proteins in mycobacterial therapy: current status and future prospects (English)

1 reference

31 August 2017

antimicrobial peptide

1 reference

Avinash Padhi

1

1 reference

31 August 2017

Mitali Sengupta

2

1 reference

31 August 2017

Srabasti Sengupta

3

1 reference

31 August 2017

Klaus H Roehm

4

1 reference

31 August 2017

Avinash Sonawane

5

1 reference

31 August 2017

12 April 2014

1 reference

31 August 2017

1 reference

31 August 2017

94

1 reference

31 August 2017

363-373

1 reference

31 August 2017

4

1 reference

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

31 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Host innate immune response to Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Immune evasion by Mycobacterium tuberculosis: living with the enemy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

STREPTOMYCIN treatment of pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

A preliminary report on the use of para-amino salicylic acid in the treatment of pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

APD2: the updated antimicrobial peptide database and its application in peptide design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Antimicrobial peptides from arachnid venoms and their microbicidal activity in the presence of commercial antibiotics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Azurophil granule proteins constitute the major mycobactericidal proteins in human neutrophils and enhance the killing of mycobacteria in macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Cationic antimicrobial peptides and biogenic silver nanoparticles kill mycobacteria without eliciting DNA damage and cytotoxicity in mouse macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Membrane-active antimicrobial peptides and human placental lysosomal extracts are highly active against mycobacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Antimicrobial peptides: promising alternatives to conventional antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Cathelicidins, multifunctional peptides of the innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Defensins: antimicrobial peptides of innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Mechanisms of antimicrobial peptide action and resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

On the physiology and pathophysiology of antimicrobial peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Kinetics of dye efflux and lipid flip-flop induced by delta-lysin in phosphatidylcholine vesicles and the mechanism of graded release by amphipathic, alpha-helical peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Molecular electroporation: a unifying concept for the description of membrane pore formation by antibacterial peptides, exemplified with NK-lysin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Describing the mechanism of antimicrobial peptide action with the interfacial activity model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Role of glycans and glycoproteins in disease development by Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Identification of defensin binding to C1 complement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Defensins purified from human granulocytes bind C1q and activate the classical complement pathway like the transmembrane glycoprotein gp41 of HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Prodefensins are matrix proteins of specific granules in human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

TLR2-dependent eosinophil interactions with mycobacteria: role of alpha-defensins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Structure, function, and membrane integration of defensins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Airway epithelial versus immune cell Stat1 function for innate defense against respiratory viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Elevated levels of alpha-defensins in plasma and BAL fluid of patients with active pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Innate response of human endothelial cells infected with mycobacteria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Human {beta}-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Mycobacterium bovis Bacillus Calmette-Guérin (BCG) stimulates human beta-defensin-2 gene transcription in human epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

The potential role of lung epithelial cells and beta-defensins in experimental latent tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Antimycobacterial agent based on mRNA encoding human beta-defensin 2 enables primary macrophages to restrict growth of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Biochemical interaction of human neutrophil peptide-1 with Mycobacterium tuberculosis H37Ra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Human neutrophil peptide defensins induce single strand DNA breaks in target cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Monocyte-chemotactic activity of defensins from human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Human defensins and LL-37 in mucosal immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Induction of β-defensins by l-isoleucine as novel immunotherapy in experimental murine tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Bacterial expression and antibiotic activities of recombinant variants of human β-defensins on pathogenic bacteria and M. tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Hypoxia triggers the expression of human β defensin 2 and antimicrobial activity against Mycobacterium tuberculosis in human macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

The role of defensins in lung biology and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Covalent structure of two novel neutrophile leucocyte-derived proteins of porcine and human origin. Neutrophile elastase homologues with strong monocyte and fibroblast chemotactic activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

CAP37-derived antimicrobial peptides have in vitro antiviral activity against adenovirus and herpes simplex virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Neutrophil primary granule proteins HBP and HNP1-3 boost bacterial phagocytosis by human and murine macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Multiple molecular forms of human lactoferrin. Identification of a class of lactoferrins that possess ribonuclease activity and lack iron-binding capacity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Lactoferrin—a multifunctional protein with antimicrobial properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Influence of lactoferrin feeding and injection against systemic staphylococcal infections in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Human milk fractions inhibit the adherence of diffusely adherent Escherichia coli (DAEC) and enteroaggregative E. coli (EAEC) to HeLa cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Killing of gram-negative bacteria by lactoferrin and lysozyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

A component of innate immunity prevents bacterial biofilm development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Influence of oral lactoferrin on Mycobacterium tuberculosis induced immunopathology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Activation of cathepsin L by the cathelin-like domain of protegrin-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Cathepsin G and neutrophil elastase contribute to lung-protective immunity against mycobacterial infections in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Human macrophages infected with a high burden of ESAT-6-expressing M. tuberculosis undergo caspase-1- and cathepsin B-independent necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Mycobacterium-containing phagosomes are accessible to early endosomes and reflect a transitional state in normal phagosome biogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Lysosomes and lysosomal cathepsins in cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Lysosomal-mitochondrial cross-talk during cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Macrophage apoptosis in response to high intracellular burden of Mycobacterium tuberculosis is mediated by a novel caspase-independent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Antimicrobial peptides in mammalian and insect host defence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

The role of the multifunctional peptide LL-37 in host defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Role of reactive oxygen species (ROS) in Mycobacterium bovis bacillus Calmette Guérin-mediated up-regulation of the human cathelicidin LL-37 in A549 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

NADPH oxidase 2 interaction with TLR2 is required for efficient innate immune responses to mycobacteria via cathelicidin expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Shedding light on the vitamin D-tuberculosis-HIV connection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

1alpha,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Quantitative analysis of phagolysosome fusion in intact cells: inhibition by mycobacterial lipoarabinomannan and rescue by an 1alpha,25-dihydroxyvitamin D3-phosphoinositide 3-kinase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Neutrophil-mediated innate immune resistance to mycobacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Neutrophils activate macrophages for intracellular killing of Leishmania major through recruitment of TLR4 by neutrophil elastase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Neutrophil serine proteases: specific regulators of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Neutrophil extracellular traps kill bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Calprotectin, an abundant cytosolic protein from human polymorphonuclear leukocytes, inhibits the growth of Borrelia burgdorferi.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Zinc-reversible antimicrobial activity of recombinant calprotectin (migration inhibitory factor-related proteins 8 and 14)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Histidine-based zinc-binding sequences and the antimicrobial activity of calprotectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Analysing the eosinophil cationic protein--a clue to the function of the eosinophil granulocyte

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Structural determinants of the eosinophil cationic protein antimicrobial activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Eosinophil cationic protein: overview of biological and genetic features.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Two human host defense ribonucleases against mycobacteria, the eosinophil cationic protein (RNase 3) and RNase 7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Bromide-dependent toxicity of eosinophil peroxidase for endothelium and isolated working rat hearts: a model for eosinophilic endocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Human eosinophil peroxidase induces surface alteration, killing, and lysis of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Oral intake of phenylbutyrate with or without vitamin D3 upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

No payoff without delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

In vitro activity of PR-39, a proline-arginine-rich peptide, against susceptible and multi-drug-resistant Mycobacterium tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Anti-tuberculosis activity of α-helical antimicrobial peptides: de novo designed L- and D-enantiomers versus L- and D-LL-37.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Designing antimicrobial peptides: form follows function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Identification and design of antimicrobial peptides for therapeutic applications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Discovery and development of a synthetic peptide derived from lactoferrin for clinical use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Inhibitory effects of the peptide (CKPV)2 on endotoxin-induced host reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Structural characterization and antimicrobial activity of the Zn(II) complex with P113 (demegen), a derivative of histatin 5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Action mechanism and structural requirements of the antimicrobial peptides, gaegurins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

The synthetic cathelicidin HHC-10 inhibits Mycobacterium bovis BCG in vitro and in C57BL/6 mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

A linguistic model for the rational design of antimicrobial peptides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Anti-mycobacterial activities of synthetic cationic α-helical peptides and their synergism with rifampicin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly, and cell selectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Improved antimicrobial peptides based on acyl-lysine oligomers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Protein, peptide and non-peptide drug PEGylation for therapeutic application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Nanotools for the delivery of antimicrobial peptides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Osteomyelitis prevention in rabbits using antimicrobial peptide hLF1-11- or gentamicin-containing calcium phosphate cement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Cathelicidin-BF, a snake cathelicidin-derived antimicrobial peptide, could be an excellent therapeutic agent for acne vulgaris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Antimicrobial peptides stage a comeback

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Antimicrobial peptide rBPI21: a translational overview from bench to clinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Safety and clinical effects of topical histatin gels in humans with experimental gingivitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Staphylococcus aureus mutant screen reveals interaction of the human antimicrobial peptide dermcidin with membrane phospholipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Efficacy of antimicrobial peptoids against Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

Late intraphagosomal hydrogen ion concentration favors the in vitro antimicrobial capacity of a 37-kilodalton cationic granule protein of human neutrophil granulocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

inferred from DOI database lookup

7 January 2021

based on heuristic

Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

inferred from DOI database lookup

7 January 2021

based on heuristic

Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2014.03.011

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TUBE.2014.03.011

1 reference

31 August 2017

1 reference